Skip to Main Content

Barney S. Graham

Professor of medicine and microbiology, biochemistry, and immunology; director of the David Satcher Global Health Equity Institute, Morehouse School of Medicine

One of the biggest public health stories of 2023 was the approval and subsequent rollout of the world’s first RSV vaccines for seniors and infants, an achievement that scientists had been working toward for decades. Immunologist and virologist Barney Graham was among the researchers whose work led to the development of the RSV vaccines by identifying and targeting the F protein found on the surface of the virus. It’s been an impactful few years for Graham, who was also instrumental in developing the spike protein target used in a number of Covid vaccines.

Industry

Location

  • Atlanta, Ga.

Advertisement

Fifty influential people shaping the future of health and life sciences across biotech, medicine, health care, policy, and health tech

View the List